ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Ernexa Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.98−0.11 (-5.26%)
Close on Oct 19, 2026
- Market cap
- $2.34M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Ernexa Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 26, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2025 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2024 | Jan 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 29, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 7, 2024 | Oct 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2024 | Sep 27, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2024 | Sep 23, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 16, 2024 | Aug 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |